PI
OSIR

Putnam Investments’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Putnam Investments’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-142,200
Closed -$2.29M – 1584
2013
Q4 		$2.29M Sell
142,200
-500
-0.4% -$7.97K 0.01% 1014
2013
Q3 		$2.37M Buy
+142,700
New +$2.11M 0.01% 997

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Putnam Investments's OSIR Position: Q1 2014 in Review

Putnam Investments sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2014, closing a stake of 142,200 shares — an estimated $2.29M sold.

Putnam Investments first reported a position in OSIR in Q3 2013 and held it in 2 quarters. The position peaked at $2.37M in Q3 2013. 63 funds tracked by Wall St. Rank hold OSIR as of Q1 2014.

  • Putnam Investments reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Putnam Investments sold 142,200 Osiris Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $2.29M.
  • Putnam Investments first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 2 quarters.
  • Putnam Investments's Osiris Therapeutics, Inc. Common Stock position peaked at $2.37M in Q3 2013.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Putnam Investments's 13F filing for Q1 2014, filed 15 May 2014.